<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="15361">Pyruvate</z:chebi> kinase type M2 (PKM2) has been reported to be involved in aerobic glycolysis and cell growth in various <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the expression pattern of PKM2 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and the correlation between PKM2 expression and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study is to investigate PKM2 expression and its possible role in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We found that expression of PKM2 was increased in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and the increased PKM2 expression was associated with later stage and lymph <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Knockdown of PKM2 suppressed the aerobic glycolysis and decreased <z:chebi fb="4" ids="24996">lactate</z:chebi> production of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> RKO cells </plain></SENT>
<SENT sid="5" pm="."><plain>Knockdown of PKM2 repressed proliferation and migration of the cells </plain></SENT>
<SENT sid="6" pm="."><plain>Inhibition of PKM2 suppressed xenograft <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> of RKO cells in vivo </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that the expression of PKM2 plays a critical role in development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, and it may provide a growth advantage for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, PKM2 might be a potential therapeutic target for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>